Industry: Chemical & Material
Published Date: 2026-06-16
Pages: 134 Pages
Report ld: 6760028
Request Sample
Customized Report
Contrast Agent API Market Size(US$)

CAGR 2026-2032
4.4%
Market Size,2032
USD 2,400
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Contrast Agent API was estimated to be worth US$ 1783 million in 2025 and is projected to reach US$ 2400 million, growing at a CAGR of 4.4% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Contrast Agent API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
The market for contrast agent APIs is driven by the increasing prevalence of medical imaging in diagnosing and monitoring various health conditions. Contrast agents improve the visualization of organs and tissues, enabling healthcare professionals to make accurate diagnoses. The demand for advanced and safe contrast agents contributes to the growth of this market.
This report provides a comprehensive view of the global market for Contrast Agent API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Contrast Agent API market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Contrast Agent API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Contrast Agent API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Contrast Agent API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Contrast Agent API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Contrast Agent API Product Introduction
1.2 Global Contrast Agent API Market Size Forecast
1.2.1 Global Contrast Agent API Sales Value (2021–2032)
1.2.2 Global Contrast Agent API Sales Volume (2021–2032)
1.2.3 Global Contrast Agent API Sales Price (2021–2032)
1.3 Contrast Agent API Market Trends & Drivers
1.3.1 Contrast Agent API Industry Trends
1.3.2 Contrast Agent API Market Drivers & Opportunities
1.3.3 Contrast Agent API Market Challenges
1.3.4 Contrast Agent API Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Contrast Agent API Players Revenue Ranking (2025)
2.2 Global Contrast Agent API Revenue by Company (2021–2026)
2.3 Global Contrast Agent API Sales Volume Ranking of Players (2025)
2.4 Global Contrast Agent API Sales Volume by Company (2021–2026)
2.5 Global Contrast Agent API Average Price by Company (2021–2026)
2.6 Key Manufacturers Contrast Agent API Manufacturing Base and Headquarters
2.7 Key Manufacturers Contrast Agent API Product Offerings
2.8 Key Manufacturers Start of Mass Production of Contrast Agent API
2.9 Contrast Agent API Market Competitive Analysis
2.9.1 Contrast Agent API Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Contrast Agent API Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contrast Agent API revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Contrast Agent API Market Classification
3.1 Introduction by Type
3.1.1 Iohexol
3.1.2 Iodixanol
3.1.3 Iopamidol
3.1.4 Ioversol
3.1.5 Others
3.1.6 Global Contrast Agent API Sales Value by Type
3.1.6.1 Global Contrast Agent API Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Contrast Agent API Sales Value, by Type (2021–2032)
3.1.6.3 Global Contrast Agent API Sales Value, by Type (%), 2021–2032
3.1.7 Global Contrast Agent API Sales Volume by Type
3.1.7.1 Global Contrast Agent API Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global Contrast Agent API Sales Volume, by Type (2021–2032)
3.1.7.3 Global Contrast Agent API Sales Volume, by Type (%), 2021–2032
3.1.8 Global Contrast Agent API Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Contrast Agent API Sales Value by Application
4.2.1 Global Contrast Agent API Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Contrast Agent API Sales Value, by Application (2021–2032)
4.2.3 Global Contrast Agent API Sales Value, by Application (%), 2021–2032
4.3 Global Contrast Agent API Sales Volume by Application
4.3.1 Global Contrast Agent API Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Contrast Agent API Sales Volume, by Application (2021–2032)
4.3.3 Global Contrast Agent API Sales Volume, by Application (%), 2021–2032
4.4 Global Contrast Agent API Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Contrast Agent API Sales Value by Region
5.1.1 Global Contrast Agent API Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Contrast Agent API Sales Value by Region (2021–2026)
5.1.3 Global Contrast Agent API Sales Value by Region (2027–2032)
5.1.4 Global Contrast Agent API Sales Value by Region (%), 2021–2032
5.2 Global Contrast Agent API Sales Volume by Region
5.2.1 Global Contrast Agent API Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Contrast Agent API Sales Volume by Region (2021–2026)
5.2.3 Global Contrast Agent API Sales Volume by Region (2027–2032)
5.2.4 Global Contrast Agent API Sales Volume by Region (%), 2021–2032
5.3 Global Contrast Agent API Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Contrast Agent API Sales Value, 2021–2032
5.4.2 North America Contrast Agent API Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Contrast Agent API Sales Value, 2021–2032
5.5.2 Europe Contrast Agent API Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Contrast Agent API Sales Value, 2021–2032
5.6.2 Asia Pacific Contrast Agent API Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Contrast Agent API Sales Value, 2021–2032
5.7.2 South America Contrast Agent API Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Contrast Agent API Sales Value, 2021–2032
5.8.2 Middle East & Africa Contrast Agent API Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Contrast Agent API Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Contrast Agent API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Contrast Agent API Sales Value, 2021–2032
6.2.2 Key Countries/Regions Contrast Agent API Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Contrast Agent API Sales Value, 2021–2032
6.3.2 United States Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Contrast Agent API Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Contrast Agent API Sales Value, 2021–2032
6.4.2 Europe Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Contrast Agent API Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Contrast Agent API Sales Value, 2021–2032
6.5.2 China Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.5.3 China Contrast Agent API Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Contrast Agent API Sales Value, 2021–2032
6.6.2 Japan Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Contrast Agent API Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Contrast Agent API Sales Value, 2021–2032
6.7.2 South Korea Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Contrast Agent API Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Contrast Agent API Sales Value, 2021–2032
6.8.2 Southeast Asia Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Contrast Agent API Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Contrast Agent API Sales Value, 2021–2032
6.9.2 India Contrast Agent API Sales Value by Type (%), 2025 vs 2032
6.9.3 India Contrast Agent API Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Information
7.1.2 GE Healthcare Introduction and Business Overview
7.1.3 GE Healthcare Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 GE Healthcare Contrast Agent API Product Offerings
7.1.5 GE Healthcare Recent Developments
7.2 Bayer
7.2.1 Bayer Company Information
7.2.2 Bayer Introduction and Business Overview
7.2.3 Bayer Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Bayer Contrast Agent API Product Offerings
7.2.5 Bayer Recent Developments
7.3 Bracco Imaging
7.3.1 Bracco Imaging Company Information
7.3.2 Bracco Imaging Introduction and Business Overview
7.3.3 Bracco Imaging Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Bracco Imaging Contrast Agent API Product Offerings
7.3.5 Bracco Imaging Recent Developments
7.4 Guerbet Group
7.4.1 Guerbet Group Company Information
7.4.2 Guerbet Group Introduction and Business Overview
7.4.3 Guerbet Group Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Guerbet Group Contrast Agent API Product Offerings
7.4.5 Guerbet Group Recent Developments
7.5 Hengrui Medicine
7.5.1 Hengrui Medicine Company Information
7.5.2 Hengrui Medicine Introduction and Business Overview
7.5.3 Hengrui Medicine Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Hengrui Medicine Contrast Agent API Product Offerings
7.5.5 Hengrui Medicine Recent Developments
7.6 Fuji Pharma
7.6.1 Fuji Pharma Company Information
7.6.2 Fuji Pharma Introduction and Business Overview
7.6.3 Fuji Pharma Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Fuji Pharma Contrast Agent API Product Offerings
7.6.5 Fuji Pharma Recent Developments
7.7 Stellite
7.7.1 Stellite Company Information
7.7.2 Stellite Introduction and Business Overview
7.7.3 Stellite Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Stellite Contrast Agent API Product Offerings
7.7.5 Stellite Recent Developments
7.8 Haichang Pharmaceutical
7.8.1 Haichang Pharmaceutical Company Information
7.8.2 Haichang Pharmaceutical Introduction and Business Overview
7.8.3 Haichang Pharmaceutical Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Haichang Pharmaceutical Contrast Agent API Product Offerings
7.8.5 Haichang Pharmaceutical Recent Developments
7.9 Brother Technology
7.9.1 Brother Technology Company Information
7.9.2 Brother Technology Introduction and Business Overview
7.9.3 Brother Technology Contrast Agent API Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Brother Technology Contrast Agent API Product Offerings
7.9.5 Brother Technology Recent Developments
8 Industry Chain Analysis
8.1 Contrast Agent API Industrial Chain
8.2 Contrast Agent API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Contrast Agent API Sales Model
8.5.2 Sales Channels
8.5.3 Contrast Agent API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Contrast Agent API market was valued at US$ 1783 million in 2025 and is anticipated to reach US$ 2400 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 133
USD 2900.00
(Single User License)
The global Contrast Agent API market size was US$ 1715 million in 2024 and is forecast to a readjusted size of US$ 2309 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
The global Contrast Agent API market is projected to grow from US$ 1715 million in 2024 to US$ 2309 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 141
USD 4900.00
(Single User License)
The global market for Contrast Agent API was valued at US$ 1715 million in the year 2024 and is projected to reach a revised size of US$ 2309 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
The global market for Contrast Agent API was estimated to be worth US$ 1715 million in 2024 and is forecast to a readjusted size of US$ 2309 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 103
USD 3950.00
(Single User License)
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
Published Date: 2024-04-12
Pages: 89
USD 4900.00
(Single User License)
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
Published Date: 2024-01-17
Pages: 92
USD 2900.00
(Single User License)
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
Published Date: 2024-01-07
Pages: 105
USD 3950.00
(Single User License)
The global Contrast Agent API market was valued at US$ 1783 million in 2025 and is anticipated to reach US$ 2400 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-04-18
Pages: 133
The global Contrast Agent API market size was US$ 1715 million in 2024 and is forecast to a readjusted size of US$ 2309 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
The global Contrast Agent API market is projected to grow from US$ 1715 million in 2024 to US$ 2309 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 141
The global market for Contrast Agent API was valued at US$ 1715 million in the year 2024 and is projected to reach a revised size of US$ 2309 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published: 2025-01-16
Pages: 95
The global market for Contrast Agent API was estimated to be worth US$ 1715 million in 2024 and is forecast to a readjusted size of US$ 2309 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 103
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
Published: 2024-04-12
Pages: 89
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
Published: 2024-01-17
Pages: 92
Contrast agent API refers to active pharmaceutical ingredients used to enhance visibility and improve the accuracy of medical imaging procedures, such as X-ray, CT scan, and MRI.
Published: 2024-01-07
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now